- call +1-201-465-4211
- email sales@mrinsights.biz
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Scope of the Report:
Plasma Protein Therapeutics is widely used to treat Hemophilia, PID and Other. The most proportion of Plasma Protein Therapeutics is to treat PID, and the proportion is about 36.1% in 2017.
North America is the largest sales place, with a consumption value market share nearly 37% in 2017. Following North America, Europe is the second largest sales place with the sales market share of 23.7% in 2017. China is an important market of Blood Product in Asia, accounting for 13.4% revenue market share of global market.
Baxter, CSL, Grifols are the leaders of the industry, with 71.6% market share in 2017, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
The worldwide market for Plasma Protein Therapeutics is expected to grow at a CAGR of roughly 6.7% over the next five years, will reach 31400 million US$ in 2024, from 21300 million US$ in 2019, according to a new study.
This report focuses on the Plasma Protein Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Coagulation Factor
Immune Globulin
Albumin
Other
Market Segment by Applications, can be divided into
Hemophilia
PID
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Protein Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plasma Protein Therapeutics, with price, sales, revenue and global market share of Plasma Protein Therapeutics in 2017 and 2018.
Chapter 3, the Plasma Protein Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Protein Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Plasma Protein Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Plasma Protein Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Plasma Protein Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Coagulation Factor
1.2.2 Immune Globulin
1.2.3 Albumin
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Hemophilia
1.3.2 PID
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shire (Baxalta)
2.1.1 Business Overview
2.1.2 Plasma Protein Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 CSL
2.2.1 Business Overview
2.2.2 Plasma Protein Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Grifols
2.3.1 Business Overview
2.3.2 Plasma Protein Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Octapharma
2.4.1 Business Overview
2.4.2 Plasma Protein Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Kedrion
2.5.1 Business Overview
2.5.2 Plasma Protein Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 LFB Group
2.6.1 Business Overview
2.6.2 Plasma Protein Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Biotest
2.7.1 Business Overview
2.7.2 Plasma Protein Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 BPL
2.8.1 Business Overview
2.8.2 Plasma Protein Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 RAAS
2.9.1 Business Overview
2.9.2 Plasma Protein Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 CBPO
2.10.1 Business Overview
2.10.2 Plasma Protein Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hualan Bio
2.11.1 Business Overview
2.11.2 Plasma Protein Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Kamada
2.12.1 Business Overview
2.12.2 Plasma Protein Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Plasma Protein Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Plasma Protein Therapeutics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Plasma Protein Therapeutics Manufacturer Market Share in 2018
3.3.2 Top 6 Plasma Protein Therapeutics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Plasma Protein Therapeutics Market Analysis by Regions
4.1 Global Plasma Protein Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Plasma Protein Therapeutics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Plasma Protein Therapeutics Revenue and Market Share by Regions (2014-2019)
4.2 North America Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
4.3 Europe Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
4.5 South America Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
5 North America Plasma Protein Therapeutics by Country
5.1 North America Plasma Protein Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Plasma Protein Therapeutics Sales and Market Share by Country (2014-2019)
5.1.2 North America Plasma Protein Therapeutics Revenue and Market Share by Country (2014-2019)
5.2 United States Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
5.3 Canada Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
5.4 Mexico Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
6 Europe Plasma Protein Therapeutics by Country
6.1 Europe Plasma Protein Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Plasma Protein Therapeutics Sales and Market Share by Country (2014-2019)
6.1.2 Europe Plasma Protein Therapeutics Revenue and Market Share by Country (2014-2019)
6.2 Germany Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
6.3 UK Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
6.4 France Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
6.5 Russia Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
6.6 Italy Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
7 Asia-Pacific Plasma Protein Therapeutics by Country
7.1 Asia-Pacific Plasma Protein Therapeutics Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Plasma Protein Therapeutics Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Plasma Protein Therapeutics Revenue and Market Share by Country (2014-2019)
7.2 China Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
7.3 Japan Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
7.4 Korea Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
7.5 India Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
8 South America Plasma Protein Therapeutics by Country
8.1 South America Plasma Protein Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Plasma Protein Therapeutics Sales and Market Share by Country (2014-2019)
8.1.2 South America Plasma Protein Therapeutics Revenue and Market Share by Country (2014-2019)
8.2 Brazil Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
8.3 Argentina Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
8.4 Colombia Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Plasma Protein Therapeutics by Countries
9.1 Middle East and Africa Plasma Protein Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Plasma Protein Therapeutics Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Plasma Protein Therapeutics Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
9.3 Turkey Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
9.4 Egypt Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
9.5 Nigeria Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
9.6 South Africa Plasma Protein Therapeutics Sales and Growth Rate (2014-2019)
10 Global Plasma Protein Therapeutics Market Segment by Type
10.1 Global Plasma Protein Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Plasma Protein Therapeutics Sales and Market Share by Type (2014-2019)
10.1.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Coagulation Factor Sales Growth and Price
10.2.1 Global Coagulation Factor Sales Growth (2014-2019)
10.2.2 Global Coagulation Factor Price (2014-2019)
10.3 Immune Globulin Sales Growth and Price
10.3.1 Global Immune Globulin Sales Growth (2014-2019)
10.3.2 Global Immune Globulin Price (2014-2019)
10.4 Albumin Sales Growth and Price
10.4.1 Global Albumin Sales Growth (2014-2019)
10.4.2 Global Albumin Price (2014-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2014-2019)
10.5.2 Global Other Price (2014-2019)
11 Global Plasma Protein Therapeutics Market Segment by Application
11.1 Global Plasma Protein Therapeutics Sales Market Share by Application (2014-2019)
11.2 Hemophilia Sales Growth (2014-2019)
11.3 PID Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Plasma Protein Therapeutics Market Forecast (2019-2024)
12.1 Global Plasma Protein Therapeutics Sales, Revenue and Growth Rate (2019-2024)
12.2 Plasma Protein Therapeutics Market Forecast by Regions (2019-2024)
12.2.1 North America Plasma Protein Therapeutics Market Forecast (2019-2024)
12.2.2 Europe Plasma Protein Therapeutics Market Forecast (2019-2024)
12.2.3 Asia-Pacific Plasma Protein Therapeutics Market Forecast (2019-2024)
12.2.4 South America Plasma Protein Therapeutics Market Forecast (2019-2024)
12.2.5 Middle East and Africa Plasma Protein Therapeutics Market Forecast (2019-2024)
12.3 Plasma Protein Therapeutics Market Forecast by Type (2019-2024)
12.3.1 Global Plasma Protein Therapeutics Sales Forecast by Type (2019-2024)
12.3.2 Global Plasma Protein Therapeutics Market Share Forecast by Type (2019-2024)
12.4 Plasma Protein Therapeutics Market Forecast by Application (2019-2024)
12.4.1 Global Plasma Protein Therapeutics Sales Forecast by Application (2019-2024)
12.4.2 Global Plasma Protein Therapeutics Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Plasma Protein Therapeutics Picture
Table Product Specifications of Plasma Protein Therapeutics
Figure Global Sales Market Share of Plasma Protein Therapeutics by Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
